Skip to search formSkip to main contentSkip to account menu

ABT 866

Known as: ABT-866, ABT866, N-(3-(1H-imidazol-4-ylmethyl)phenyl)ethanesulfonamide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine…
N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1) is a novel alpha(1) agent having the unique profile of alpha… 
2002
2002
ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes.
N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide, maleate (ABT-866) is a novel alpha(1)-adrenoceptor agent with mixed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)